EG19080A - Process for preparing of interphenylene 7-oxabicycloheptyl subsituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasaspatic - Google Patents

Process for preparing of interphenylene 7-oxabicycloheptyl subsituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasaspatic

Info

Publication number
EG19080A
EG19080A EG20890A EG20890A EG19080A EG 19080 A EG19080 A EG 19080A EG 20890 A EG20890 A EG 20890A EG 20890 A EG20890 A EG 20890A EG 19080 A EG19080 A EG 19080A
Authority
EG
Egypt
Prior art keywords
aralkyl
aryl
interphenylene
thrombotic
lower alkyl
Prior art date
Application number
EG20890A
Other languages
English (en)
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Application granted granted Critical
Publication of EG19080A publication Critical patent/EG19080A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
    • C07C17/16—Preparation of halogenated hydrocarbons by replacement by halogens of hydroxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EG20890A 1989-04-03 1990-04-03 Process for preparing of interphenylene 7-oxabicycloheptyl subsituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasaspatic EG19080A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33407089A 1989-04-03 1989-04-03

Publications (1)

Publication Number Publication Date
EG19080A true EG19080A (en) 1994-07-30

Family

ID=23305449

Family Applications (1)

Application Number Title Priority Date Filing Date
EG20890A EG19080A (en) 1989-04-03 1990-04-03 Process for preparing of interphenylene 7-oxabicycloheptyl subsituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasaspatic

Country Status (28)

Country Link
EP (1) EP0391652B1 (fr)
JP (1) JP2989213B2 (fr)
KR (1) KR0160508B1 (fr)
CN (1) CN1028529C (fr)
AT (1) ATE119903T1 (fr)
AU (1) AU632797B2 (fr)
CA (1) CA2012267C (fr)
CY (1) CY1851A (fr)
CZ (1) CZ285656B6 (fr)
DD (1) DD293353A5 (fr)
DE (1) DE69017735T2 (fr)
DK (1) DK0391652T3 (fr)
EG (1) EG19080A (fr)
ES (1) ES2069682T3 (fr)
FI (1) FI97543C (fr)
HK (1) HK110495A (fr)
HU (2) HUT54368A (fr)
IE (1) IE67274B1 (fr)
IL (1) IL93771A (fr)
MX (1) MX20132A (fr)
MY (1) MY106245A (fr)
NO (1) NO177425C (fr)
NZ (1) NZ232897A (fr)
PL (1) PL164345B1 (fr)
PT (1) PT93641B (fr)
RU (1) RU2059618C1 (fr)
SK (1) SK158290A3 (fr)
ZA (1) ZA902559B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ233600A (en) * 1989-06-12 1992-10-28 Squibb & Sons Inc 7-oxabicyclo(2.2.1)heptane imidazole prostaglandin analogs and pharmaceutical compositions
US4977174A (en) * 1989-06-12 1990-12-11 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane imidazole prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
ZA911453B (en) * 1990-03-19 1991-11-27 Squibb & Sons Inc Method of protecting against and/or treating ulcerative gastrointestinal conditions using a thromoboxane,a2 receptor antagonist and combination useful in preventing and/or treating ulcers and/or inflammation
US5290799A (en) * 1990-09-19 1994-03-01 E. R. Squibb & Sons, Inc. 7-oxabicycloheptyl substituted heterocyclic thioamide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
US5550248A (en) * 1990-11-29 1996-08-27 E.R. Squibb & Sons, Inc. Substituted stryl heterocyclic amido prostaglandin analogs
US5135939A (en) * 1991-01-28 1992-08-04 E. R. Squibb & Sons, Inc. Heterocyclic ketone prostaglandin analogs
US5238951A (en) * 1991-02-01 1993-08-24 E. R. Squibb & Sons, Inc. Heterocyclic amido prostaglandin analogs
IE920039A1 (en) * 1991-02-01 1992-08-12 Squibb & Sons Inc Heterocyclic amido prostaglandin analogs
US5158967A (en) * 1991-06-12 1992-10-27 E. R. Squibb & Sons, Inc. 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
US5162352A (en) * 1991-08-22 1992-11-10 E. R. Squibb & Sons, Inc. 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs
CA2081679A1 (fr) * 1991-11-27 1993-05-28 Raj N. Misra Analogues de prostaglandines amidiques heterocycliques de type pem-dialkyl-7-oxabicycloheptyle substitues utiles dans le traitement des thromboses et des spasmes vasculaires
US5281716A (en) * 1992-06-18 1994-01-25 Bristol-Myers Squibb Company Method for preparing 7-oxabicycloheptyl substituted oxazole amide prostaglandin analog intermediates useful in the preparation of anti-thrombotic and anti-vasospastic compounds
US5399725A (en) * 1993-05-27 1995-03-21 Bristol-Myers Squibb Co. 7-oxabicycloheptane carboxylic acid prostaglandin analog intermediates useful in the preparation of anti-thrombotic and anti-vasospastic compounds and method for preparing same
US5539126A (en) * 1994-04-20 1996-07-23 Bristol-Myers Squibb Company Method for preparing homochiral maleimide intermediates, via silylation techniques
US5849766A (en) * 1996-05-31 1998-12-15 Eli Lilly And Company Carbamoyl substituted heterocycles
US5849922A (en) * 1996-05-31 1998-12-15 Eli Lilly And Company Preparation of substituted alkenoic acids
US5856584A (en) * 1997-08-06 1999-01-05 The Nutrasweet Company Preparation of 3,3-dimethylbutyraldehyde by oxidation of 3, 3-dimethylbutanol
US5905175A (en) * 1998-05-20 1999-05-18 The Nutrasweet Company Synthesis and purification of 3,3-dimethylbutyraldehyde via oxidation of 1-chloro-3,3-dimethylbutane with dimethyl sulfoxide
US6407250B1 (en) 2000-09-14 2002-06-18 Allergan Sales, Inc. Interphenylene 7-oxabicyclic [2.2.1] heptane oxazoles as prostaglandin F2a antagonists
US6511999B2 (en) 2000-09-14 2003-01-28 Allergan, Inc. Interheteroaryl 7-oxabicyclic [2.2.1]heptane oxazoles as prostaglandin F2α antagonists
US6369089B1 (en) 2000-09-14 2002-04-09 Allergan Sales, Inc. Interheteroaryl 7-oxabicyclic [2.2.1]heptane oxazoles as prostaglandin F2α antagonists
FR2838437B1 (fr) * 2002-04-11 2004-06-04 Aventis Pharma Sa Procedes de preparation de combretastatines
US7045634B2 (en) 2003-09-05 2006-05-16 Allergan, Inc. Prostamide receptor antagonists
AU2010232556A1 (en) 2009-04-02 2011-11-03 Allergan, Inc. Prostaglandin E receptor antagonists
CA2837300A1 (fr) * 2011-05-25 2012-11-29 Allergan, Inc. Inhibiteurs d'hydrolase d'amide d'acide gras destines a traiter la douleur

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4652576A (en) * 1985-10-18 1987-03-24 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted amide-carbamate prostaglandin analogs
US4663337A (en) * 1986-04-18 1987-05-05 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted amides useful in the treatment of thrombotic disease
CA2006355A1 (fr) * 1988-12-23 1990-06-23 Philip M. Sher Amide heterocyclique de 7-oxabicycloheptyl substitue analogues de la prostaglandine utiles dans le traitement des affections thrombotiques et vasospastiques
NZ233600A (en) * 1989-06-12 1992-10-28 Squibb & Sons Inc 7-oxabicyclo(2.2.1)heptane imidazole prostaglandin analogs and pharmaceutical compositions

Also Published As

Publication number Publication date
SK278865B6 (sk) 1998-04-08
HU9002048D0 (en) 1990-08-28
FI901645A0 (fi) 1990-04-02
ES2069682T3 (es) 1995-05-16
CA2012267C (fr) 2001-02-27
AU632797B2 (en) 1993-01-14
ZA902559B (en) 1991-01-30
IL93771A (en) 1995-06-29
CN1046163A (zh) 1990-10-17
PT93641A (pt) 1990-11-20
DD293353A5 (de) 1991-08-29
DK0391652T3 (da) 1995-04-03
CA2012267A1 (fr) 1990-10-03
CZ158290A3 (cs) 1999-06-16
NO177425C (no) 1995-09-20
NO177425B (no) 1995-06-06
MY106245A (en) 1995-04-29
ATE119903T1 (de) 1995-04-15
HU210713A9 (en) 1995-06-28
EP0391652B1 (fr) 1995-03-15
AU5206490A (en) 1990-10-04
CY1851A (en) 1996-03-08
KR0160508B1 (ko) 1998-12-01
JPH02289579A (ja) 1990-11-29
RU2059618C1 (ru) 1996-05-10
KR900016197A (ko) 1990-11-12
NZ232897A (en) 1992-12-23
PL284600A1 (en) 1991-01-14
DE69017735D1 (de) 1995-04-20
NO901494L (no) 1990-10-04
SK158290A3 (en) 1998-04-08
IE901095L (en) 1990-10-03
JP2989213B2 (ja) 1999-12-13
HUT54368A (en) 1991-02-28
CN1028529C (zh) 1995-05-24
IL93771A0 (en) 1990-12-23
CZ285656B6 (cs) 1999-10-13
FI97543C (fi) 1997-01-10
NO901494D0 (no) 1990-04-02
HK110495A (en) 1995-07-14
PL164345B1 (pl) 1994-07-29
MX20132A (es) 1994-01-31
DE69017735T2 (de) 1995-08-17
PT93641B (pt) 1996-06-28
IE67274B1 (en) 1996-03-20
EP0391652A1 (fr) 1990-10-10
FI97543B (fi) 1996-09-30

Similar Documents

Publication Publication Date Title
EG19080A (en) Process for preparing of interphenylene 7-oxabicycloheptyl subsituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasaspatic
EP0535928A3 (en) Process for producing intermediates for use in production of alkoxyiminoacetamides and intermediates to be used therein
DE69201948D1 (de) Verwendung von 1,3-oxathiolanalogen von nukleosiden zur herstellung eines arzneimittels zur behandlung von hepatitis-b.
DE69201959D1 (de) Verfahren zur Herstellung von 6,12-Dihydro-6-hydroxy-cannabidiol und dessen Anwendung zur Herstellung von trans-delta-9-Tetrahydrocannabinol.
SI0657428T1 (en) Preparation of 3,4,4-trisubstitutedpiperidinyl-n-alkylcarboxylates and intermediates, useful as opioid antagonists
PT83388A (en) Process for preparing substituted bridged diazabicycloalkyl quinolone carboxilic acids
DE69329887D1 (de) Thienobenzodiazepinderivate zur Behandlung von Störungen des Zentralnervensystems
ES2057126T3 (es) Metodo de tratamiento de la caquexia y algunos nuevos compuestos para utilizar en este metodo.
ATE65402T1 (de) Ifosfamid-mesna-lyophilisat und verfahren zu dessen herstellung.
NZ234672A (en) N-(1,2,3,4-tetrahydro-9-acridinyl)amide and carbamate derivatives and pharmaceutical compositions
DE59008170D1 (de) Verfahren zur Herstellung mikronisierter bioabbaubarer Partikel.
DE3873578D1 (de) Verwendung von tetrahydrobenz(c,d)indol-6-carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
HK201196A (en) Cyclopropane derivatives
PT86032A (de) Ifosfamid-lyophilisat und verfahren zu dessen herstellung
HUT57211A (en) Process for producing pyrrolo-pyrimidine derivatives, pharmaceutically acceptable salts thereof and pahrmaceutical compositions containing them as active components
GR3006606T3 (fr)
ATE165596T1 (de) Verfahren zur herstellung von insektiziden, acariziden und molluskiziden 2-halo-pyrrol-3- carbonitrilen
HUT34478A (en) Process for producing hexahydro-pyrrolo/2.1-a/isoquinoline derivatives and pharmaceutical compositions containing them
HUT56559A (en) Process for producing ascorbinic acid derivatives and pharma
ATE35679T1 (de) Verfahren zur herstellung von cis-3,3,5trimethylcyclohexyl-d,l-alpha-(3-pyridincarboxy - phenylacetat.